Fredag 21 Augusti | 23:54:32 Europe / Stockholm
Est. tid*
2027-02-24 08:30 Bokslutskommuniké 2026
2026-11-02 18:15 Kvartalsrapport 2026-Q3
2026-08-26 N/A Extra Bolagsstämma 2026
2026-08-14 - Kvartalsrapport 2026-Q2
2026-05-31 - Kvartalsrapport 2026-Q1
2026-05-27 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2026-05-26 - Årsstämma
2026-03-27 - Bokslutskommuniké 2025
2025-11-14 - Kvartalsrapport 2025-Q3
2025-08-01 - Kvartalsrapport 2025-Q2
2025-05-27 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2025-05-26 - Årsstämma
2025-05-22 - Kvartalsrapport 2025-Q1
2025-03-27 - Bokslutskommuniké 2024
2024-12-30 - Extra Bolagsstämma 2025
2024-10-24 - Kvartalsrapport 2024-Q3
2024-10-04 - Extra Bolagsstämma 2024
2024-07-18 - Kvartalsrapport 2024-Q2
2024-04-26 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2024-04-25 - Årsstämma
2024-04-18 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-10-25 - Kvartalsrapport 2023-Q3
2023-07-18 - Kvartalsrapport 2023-Q2
2023-04-27 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2023-04-26 - Årsstämma
2023-02-16 - Bokslutskommuniké 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-17 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2022-05-17 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-14 - Extra Bolagsstämma 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-17 - Kvartalsrapport 2021-Q2
2021-05-14 - Kvartalsrapport 2021-Q1
2021-05-03 - X-dag ordinarie utdelning MAGLE 0.00 SEK
2021-04-18 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-11-27 - Extra Bolagsstämma 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-14 - Kvartalsrapport 2020-Q2
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Magle Chemoswed bygger på strategiska förvärv som syftar till att driva tillväxt och diversifiera risker. Koncernen omfattar tre verksamhetsområden. Magle Chemoswed, en kontraktsutvecklings- och tillverkningsorganisation (CDMO). Magle PharmaCept, ett försäljnings- och marknadsföringsföretag för utveckling och direktförsäljning av koncernens medicintekniska produkter, och Magle Biopolymers A/S, en specialiserad tillverkningsorganisation för Dextran-teknologi.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Magle Group announces additional drawdown under bridge loan facility

2026-08-21 18:30:00

Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") announces that its wholly owned subsidiary Magle Chemoswed AB (the "Borrower") has requested an additional drawdown of SEK 15 million under the bridge loan facility agreement (the "Bridge Loan Agreement") previously entered into with certain existing bondholders, as announced on 27 May 2026, and that the lenders under the Bridge Loan Agreement have, today on 21 August 2026, approved such additional drawdown. The proceeds of the additional drawdown will be applied towards the repayment of SEK 15 million due by 31 August 2026 under the structured repayment schedule agreed with Danske Bank A/S in respect of the Company's credit facility with Danske Bank A/S (the "Danske Bank Facility"), as announced on 30 June 2026.

As announced on 27 May 2026, the Company and the Borrower entered into the Bridge Loan Agreement with a group of existing bondholders, providing for financing of up to SEK 60 million, of which SEK 25 million was initially drawn. The Borrower has requested an additional drawdown of SEK 15 million, and the lenders under the Bridge Loan Agreement have, today on 21 August 2026, approved such additional drawdown. Following such drawdown, the total amount drawn under the Bridge Loan Agreement will amount to SEK 40 million. In accordance with the terms of the Bridge Loan Agreement, the Company shall issue additional bonus bonds to the lenders in an aggregate nominal amount equal to 5.00 per cent. of the additional drawdown amount, being SEK 750,000.

Further, on 30 June 2026, the Company announced that it had entered into an agreement with Danske Bank A/S regarding a structured repayment schedule for the outstanding debt under the Danske Bank Facility, pursuant to which a repayment of SEK 15 million is to be made by 31 August 2026. The proceeds of the additional drawdown will be applied towards such repayment.